These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7527867)

  • 1. [T cell immunity to proteolipid protein (PLP) in multiple sclerosis (MS): identification of DR2-associated PLP determinants and conserved TCR CDR3 motifs].
    Kondo T; Ohashi T
    Nihon Rinsho; 1994 Nov; 52(11):2940-5. PubMed ID: 7527867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans.
    Markovic-Plese S; Fukaura H; Zhang J; al-Sabbagh A; Southwood S; Sette A; Kuchroo VK; Hafler DA
    J Immunol; 1995 Jul; 155(2):982-92. PubMed ID: 7541828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
    Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2,w15-associated determinant.
    Ohashi T; Yamamura T; Inobe J; Kondo T; Kunishita T; Tabira T
    Int Immunol; 1995 Nov; 7(11):1771-8. PubMed ID: 8580075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis.
    Hong J; Zang YC; Tejada-Simon MV; Kozovska M; Li S; Singh RA; Yang D; Rivera VM; Killian JK; Zhang JZ
    J Immunol; 1999 Sep; 163(6):3530-8. PubMed ID: 10477628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.
    Hafler DA; Benjamin DS; Burks J; Weiner HL
    J Immunol; 1987 Jul; 139(1):68-72. PubMed ID: 2438352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.
    Sun JB; Olsson T; Wang WZ; Xiao BG; Kostulas V; Fredrikson S; Ekre HP; Link H
    Eur J Immunol; 1991 Jun; 21(6):1461-8. PubMed ID: 1710567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
    Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
    Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein.
    Chou YK; Henderikx P; Vainiene M; Whitham R; Bourdette D; Chou CH; Hashim G; Offner H; Vandenbark AA
    J Neurosci Res; 1991 Feb; 28(2):280-90. PubMed ID: 1709690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence.
    Vandevyver C; Mertens N; van den Elsen P; Medaer R; Raus J; Zhang J
    Eur J Immunol; 1995 Apr; 25(4):958-68. PubMed ID: 7537675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
    Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
    J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis.
    Correale J; Gilmore W; McMillan M; Li S; McCarthy K; Le T; Weiner LP
    J Immunol; 1995 Mar; 154(6):2959-68. PubMed ID: 7533188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.
    Warren KG; Catz I; Johnson E; Mielke B
    Ann Neurol; 1994 Mar; 35(3):280-9. PubMed ID: 7510098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis.
    Salvetti M; Ristori G; D'Amato M; Buttinelli C; Falcone M; Fieschi C; Wekerle H; Pozzilli C
    Eur J Immunol; 1993 Jun; 23(6):1232-9. PubMed ID: 7684682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides.
    Chou YK; Morrison WJ; Weinberg AD; Dedrick R; Whitham R; Bourdette DN; Hashim G; Offner H; Vandenbark AA
    J Immunol; 1994 Mar; 152(5):2520-9. PubMed ID: 7510747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis.
    Zang YC; Kozovska M; Aebischer I; Li S; Boehme S; Crowe P; Rivera VM; Zhang JZ
    Int Immunol; 1998 Jul; 10(7):991-8. PubMed ID: 9701037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
    Bourdette DN; Chou YK; Whitham RH; Buckner J; Kwon HJ; Nepom GT; Buenafe A; Cooper SA; Allegretta M; Hashim GA; Offner H; Vandenbark AA
    J Immunol; 1998 Jul; 161(2):1034-44. PubMed ID: 9670985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
    Kawamura K; Yamamura T; Yokoyama K; Chui DH; Fukui Y; Sasazuki T; Inoko H; David CS; Tabira T
    J Clin Invest; 2000 Apr; 105(7):977-84. PubMed ID: 10841661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.